Quantcast

Book Yvonne Greenstreet

33
Yvonne Greenstreet has seized opportunities to try new things in her career, even when those around her weren't as enthusiastic about them. And her willingness to leave her comfort zone has led to a rich career that has touched on important new drugs for patients from GlaxoSmithKline ($GSK) and now Pfizer, where she's been a senior executive since early 2011. [+]
This is a discussion about the above article. Concerns about the topic, its accuracy, inclusion of information etc. should be discussed here. Off-topic discussion not pertaining to the topic of the page will be removed.